Search

Devesh Khare

Examiner (ID: 9272)

Most Active Art Unit
1623
Art Unit(s)
1623
Total Applications
460
Issued Applications
314
Pending Applications
34
Abandoned Applications
112

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6697298 [patent_doc_number] => 20030109492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Non-inclusion cyclodextrin complexes' [patent_app_type] => new [patent_app_number] => 10/272936 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12889 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109492.pdf [firstpage_image] =>[orig_patent_app_number] => 10272936 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/272936
Non-inclusion cyclodextrin complexes Oct 17, 2002 Issued
Array ( [id] => 6652233 [patent_doc_number] => 20030105165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Gap junctions and EDHF' [patent_app_type] => new [patent_app_number] => 10/270663 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9558 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105165.pdf [firstpage_image] =>[orig_patent_app_number] => 10270663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/270663
Gap junctions and EDHF Oct 15, 2002 Abandoned
Array ( [id] => 720607 [patent_doc_number] => 07049436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/267686 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 4874 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049436.pdf [firstpage_image] =>[orig_patent_app_number] => 10267686 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/267686
Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use Oct 8, 2002 Issued
Array ( [id] => 6822109 [patent_doc_number] => 20030220270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Mono-and disaccharide derivatives' [patent_app_type] => new [patent_app_number] => 10/148441 [patent_app_country] => US [patent_app_date] => 2002-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26737 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220270.pdf [firstpage_image] =>[orig_patent_app_number] => 10148441 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/148441
Mono-and disaccharide derivatives Oct 6, 2002 Abandoned
Array ( [id] => 6678908 [patent_doc_number] => 20030229049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Method and pharmaceutical to treat spinal discs' [patent_app_type] => new [patent_app_number] => 10/441130 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2292 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229049.pdf [firstpage_image] =>[orig_patent_app_number] => 10441130 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/441130
Method and pharmaceutical to treat spinal discs Oct 3, 2002 Abandoned
Array ( [id] => 7367109 [patent_doc_number] => 20040006007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Methods and compositions for treating hepatitis C virus using 4\'-modified nucleosides' [patent_app_type] => new [patent_app_number] => 10/261244 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31547 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 63 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006007.pdf [firstpage_image] =>[orig_patent_app_number] => 10261244 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/261244
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Sep 29, 2002 Issued
Array ( [id] => 1080677 [patent_doc_number] => 06835720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-28 [patent_title] => 'Compounds having antiviral activity' [patent_app_type] => B2 [patent_app_number] => 10/252036 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 20400 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835720.pdf [firstpage_image] =>[orig_patent_app_number] => 10252036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/252036
Compounds having antiviral activity Sep 22, 2002 Issued
Array ( [id] => 988265 [patent_doc_number] => 06921820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Method for forming cellulose' [patent_app_type] => utility [patent_app_number] => 10/247623 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 6787 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921820.pdf [firstpage_image] =>[orig_patent_app_number] => 10247623 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/247623
Method for forming cellulose Sep 19, 2002 Issued
Array ( [id] => 6852032 [patent_doc_number] => 20030144235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => '4\'-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof' [patent_app_type] => new [patent_app_number] => 10/237192 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5136 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144235.pdf [firstpage_image] =>[orig_patent_app_number] => 10237192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/237192
4′-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof Sep 8, 2002 Issued
Array ( [id] => 6818249 [patent_doc_number] => 20030069207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration' [patent_app_type] => new [patent_app_number] => 10/237918 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2808 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069207.pdf [firstpage_image] =>[orig_patent_app_number] => 10237918 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/237918
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration Sep 8, 2002 Issued
Array ( [id] => 6716577 [patent_doc_number] => 20030027925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Oligosaccharide synthesis' [patent_app_type] => new [patent_app_number] => 10/231909 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12130 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027925.pdf [firstpage_image] =>[orig_patent_app_number] => 10231909 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231909
Oligosaccharide synthesis Aug 29, 2002 Issued
Array ( [id] => 6792743 [patent_doc_number] => 20030088087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Synthesis, deprotection, analysis & purification of RNA & ribozymes' [patent_app_type] => new [patent_app_number] => 10/231874 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12018 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20030088087.pdf [firstpage_image] =>[orig_patent_app_number] => 10231874 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231874
Synthesis, deprotection, analysis and purification of RNA and ribozymes Aug 29, 2002 Issued
Array ( [id] => 6711824 [patent_doc_number] => 20030171573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer' [patent_app_type] => new [patent_app_number] => 10/230394 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13634 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171573.pdf [firstpage_image] =>[orig_patent_app_number] => 10230394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/230394
Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer Aug 28, 2002 Abandoned
Array ( [id] => 6651219 [patent_doc_number] => 20030105029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Drugs, foods or drinks with the use of algae-derived physiologically active substances' [patent_app_type] => new [patent_app_number] => 10/228195 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 28529 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105029.pdf [firstpage_image] =>[orig_patent_app_number] => 10228195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/228195
Drugs, foods or drinks with the use of algae-derived physiologically active substances Aug 26, 2002 Issued
Array ( [id] => 6783506 [patent_doc_number] => 20030064954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds' [patent_app_type] => new [patent_app_number] => 10/204640 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19725 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064954.pdf [firstpage_image] =>[orig_patent_app_number] => 10204640 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/204640
Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds Aug 21, 2002 Abandoned
Array ( [id] => 1025188 [patent_doc_number] => 06884880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Process for the preparation of 9-β-anomeric nucleoside analogs' [patent_app_type] => utility [patent_app_number] => 10/225032 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6499 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884880.pdf [firstpage_image] =>[orig_patent_app_number] => 10225032 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/225032
Process for the preparation of 9-β-anomeric nucleoside analogs Aug 20, 2002 Issued
Array ( [id] => 6628678 [patent_doc_number] => 20030005857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Saccharide compound and a method of producing the same' [patent_app_type] => new [patent_app_number] => 10/223364 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7364 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20030005857.pdf [firstpage_image] =>[orig_patent_app_number] => 10223364 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/223364
Saccharide compound and a method of producing the same Aug 19, 2002 Abandoned
Array ( [id] => 6702152 [patent_doc_number] => 20030225032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/217551 [patent_app_country] => US [patent_app_date] => 2002-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2135 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225032.pdf [firstpage_image] =>[orig_patent_app_number] => 10217551 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/217551
Pharmaceutical composition Aug 13, 2002 Issued
Array ( [id] => 6658047 [patent_doc_number] => 20030078232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Adenosine receptor A3 agonists' [patent_app_type] => new [patent_app_number] => 10/212896 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13859 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078232.pdf [firstpage_image] =>[orig_patent_app_number] => 10212896 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/212896
Adenosine receptor A3 agonists Aug 4, 2002 Abandoned
Array ( [id] => 7674665 [patent_doc_number] => 20040127453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Method for treating diseases associated with abnormal kinase activity' [patent_app_type] => new [patent_app_number] => 10/206854 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15707 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127453.pdf [firstpage_image] =>[orig_patent_app_number] => 10206854 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/206854
Method for treating diseases associated with abnormal kinase activity Jul 25, 2002 Issued
Menu